Talking Biotech with Dr. Kevin Folta

In this episode of the Talking Biotech podcast, Dr. Kevin Folta discusses the introduction of the Purple Tomato by Norfolk Healthy Produce. Dr. Nathan Pumplin, CEO of Norfolk Healthy Produce, shares …

Social media teems with false information about food and farming.  Influencers cover Instagram and Facebook with claims that food is poison and farmers are "dousing" crops in dangerous chemicals. It …

In this episode of the Talking Biotech podcast, Kevin Folta interviews John Rizk, a pharmacist and epidemiologist, about M-Pox (formerly known as monkeypox). They discuss the emergence of M-Pox, its …

n this episode, Dr. Kevin Folta speaks with Joe Damond about the rapidly evolving landscape of life sciences, particularly focusing on gene and cell therapies. They discuss the exciting advancements …

In this episode of the Talking Biotech podcast, Kevin Folta interviews Jenny Du, co-founder and senior vice president of operations at Apeel, a company focused on reducing food waste through innovati…

Citrus greening disease or HLB has severely impacted Florida citrus production.  And while many solutions have been proposed, there is interest in a number of trees that have shown to not show sympto…

In this conversation, Dr. Kevin Folta and Vance Crowe discuss the evolving landscape of agriculture communication, the rise of pseudoscience, and the cultural shifts affecting public trust in science…

We regularly discuss a small suite of commercial crops that have been genetically enhanced with transgenes.  However, one additional genotype was transformed long ago, and approved for use in the USA…

In 2013 a number of county ordinances sought to end the use of biotech crops on various Hawaiian islands. Hawaii's warm year-'round climate permits several corn seasons a year, so seed corn for the m…

Great products and ideas are everywhere, yet limited by the ability to actually produce them in needed quantitites. The technologies from Sunflower Therapeutics enable bioprocess applications through…

T-cells are a critical part of the adaptive immune system, actively targeting problematic invaders.  From pathogens to cancers, T-cells seek and destroy potentially dangerous cells, and maintain a me…

Disinformation clouds the public understanding of science, especially technology in agriculture and medicine. So when a leading journal publishes false information, academic experts have an obligatio…

Wikipedia is the go-to source for many people when starting to research a subject. But is the information correct, or does the information even exist in Wikipedia at all?  Susan Gerbic has been train…

Crop genetic engineering has focused primarily on large-acreage crops like corn.  But what about the universe of specialty crops that tantalize consumers, things like blackberries or salad greens?  P…

Advancement of a new drug from pre-clinical trials to clinical trials is a pivotal time in validation of its therapeutic effects and safety.  A panel of experts discusses the process. 

Today's episode marks the beginning of the 10th year of the Talking Biotech Podcast.  To celebrate, Drs. Liza Dunn and Kevin Folta discuss the last decade of biotech breakthroughs and communications …

Chronic inflammation goes hand-in-hand with many diseases, complicating symptoms and affecting routes of treatment. What is the molecular basis of inflammation, and can it be targeted by new drugs? S…

Strategic partnerships are becoming more important in development and deployment of biotechnology solutions. Today's panel discusses the way partnerships are formed, some of the important considerati…